A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response

Human Gene Therapy, Ahead of Print.

Source: Human Gene Therapy - October 30, 2023 Category: Genetics & Stem Cells Authors: Cong Li Yuying Tian Fang Sun Guanglin Lei Jinxia Cheng Chongyu Tian Hongyu Yu Zhuoya Deng Shuai Lu Lishi Wang Ruixue Xiao Changqing Bai Penghui Yang Source Type: research